Molecular-Docking Study of quinazolin-4(3H)-one derivatives against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment. Int. J. Pharm. Sci. Drug Res. [Internet]. 2020 Sep. 30 [cited 2025 Sep. 21];12(5):572-5. Available from: https://ijpsdronline.com/index.php/journal/article/view/1817